Does Rallies show 13F holders for ATHA?

Yes. Rallies tracks hedge fund and 13F ownership data for ATHA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ATHA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ATHA. It does not provide personalized investment advice.

ATHA (Athira Pharma, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Athira Pharma, Inc. Common Stock (ATHA) is a publicly traded Healthcare sector company. As of May 21, 2026, ATHA trades at $6.75 with a market cap of $26.62M and a P/E ratio of -0.27. ATHA moved -7.53% today. Year to date, ATHA is +1566.67%; over the trailing twelve months it is +1042.91%. Its 52-week range spans $0.22 to $8.36. Analyst consensus is hold with an average price target of $13.33. Rallies surfaces ATHA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ATHA stock?

Hedge funds tracked by Rallies that own ATHA include Panagora Asset. The latest tracked quarter is Mar 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Athira Pharma, Inc. Common Stock.

ATHA Key Metrics

Key financial metrics for ATHA
Metric	Value
Price	$6.75
Market Cap	$26.62M
P/E Ratio	-0.27
EPS	$-24.70
Dividend Yield	0.00%
52-Week High	$8.36
52-Week Low	$0.22
Volume	70.26K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-105.61M
Gross Margin	0.00%

Top Hedge Funds Holding ATHA

Panagora Asset holds 148.80K shares of ATHA, changed +0.00% as of Mar 31, 2023.

Latest ATHA News

ATHA Energy Secures US$20M Five-Year Debenture with 12% Coupon Convertible at C$0.85 — Jan 13, 2026
ATHA Energy Secures US$20M Convertible Debenture Financing at 12% Coupon — Jan 13, 2026

Recent ATHA Insider Trades

San Martin Javier sold 1.64K (~$11.31K) on Jan 2, 2026.
Litton Mark James sold 2.59K (~$17.79K) on Jan 2, 2026.
Renninger Robert sold 297 (~$2.04K) on Jan 2, 2026.

ATHA Analyst Consensus

5 analysts cover ATHA: 0 strong buy, 0 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $13.33.

Common questions about ATHA

Who owns ATHA stock?: Hedge funds tracked by Rallies that own ATHA include Panagora Asset. The latest tracked quarter is Mar 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Athira Pharma, Inc. Common Stock.
Does Rallies show 13F holders for ATHA?: Yes. Rallies tracks hedge fund and 13F ownership data for ATHA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ATHA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ATHA. It does not provide personalized investment advice.